Investors looking for promising stocks to consider this Friday should keep an eye on Apollo Hospitals Enterprise Ltd., Dr. Lal Path Labs Ltd., Hindustan Unilever Ltd., Hindustan Petroleum Corp., and NBCC (India) Ltd.. These companies have recently received favorable recommendations from analysts, indicating potential growth opportunities in the market.
Apollo Hospitals Enterprise Ltd.
Renowned for its healthcare services, Apollo Hospitals Enterprise Ltd. has been given a "buy" rating by HDFC Securities’ analyst Rajani. The projected target price stands at ₹6,840.85, reflecting a potential upside of 2.33% from its last closing price. Investors are advised to set a stop loss at ₹6,720 to mitigate risks.
Dr. Lal Path Labs Ltd.
In the healthcare sector, Dr. Lal Path Labs Ltd. also shines with a "buy" recommendation from Aditya Arora, the founder of Adlytick.in. The target price for this stock is ₹2,830, which suggests an upside of 6.79% from its previous closing. To manage investment risk, a stop loss should be placed at ₹2,500.
Hindustan Unilever Ltd.
The consumer goods giant Hindustan Unilever Ltd. has caught the attention of analysts, receiving a "buy" call from Rajani. The target price is set at ₹2,425, indicating a 3.24% upside potential based on the last closing price. Investors should consider a stop loss at ₹2,300 to ensure protection against market volatility.
Hindustan Petroleum Corp.
Energy sector stock Hindustan Petroleum Corp. has also garnered a "buy" rating from Ajit Mishra of Religare Broking. The target price forecast is ₹395, suggesting a possible upside of 4.14% from its recent closing price. A stop loss of ₹530 is recommended for those looking to invest.
NBCC (India) Ltd.
Finally, NBCC (India) Ltd. has been highlighted by Aditya Arora as a stock to buy. The anticipated target price is ₹92.50, which indicates an upside of 6.32% from the last closing figure. Investors should note a stop loss of ₹81.50 to safeguard their investment.
Summary of Recommendations
- Apollo Hospitals: Target Price: ₹6,840.85 | Stop Loss: ₹6,720
- Dr. Lal Path Labs: Target Price: ₹2,830 | Stop Loss: ₹2,500
- Hindustan Unilever: Target Price: ₹2,425 | Stop Loss: ₹2,300
- Hindustan Petroleum: Target Price: ₹395 | Stop Loss: ₹530
- NBCC (India): Target Price: ₹92.50 | Stop Loss: ₹81.50
As you explore these investment opportunities, ensure to conduct your own research or consult with a financial advisor to align with your investment strategy. Happy trading!
